The prevention of canine leishmaniasis and its impact on public health

Trends in Parasitology

Volumn 29, Issue 7, 2013, Pages 339-345

  Otranto, Domenico ^a   Dantas Torres, Filipe ^a,b  

^a UNIVERSITY OF BARI   (Italy)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Canine leishmaniasis; CanL; Control; Dogs; Leishmania; Pyrethroids; Vaccines; Zoonosis

Indexed keywords

DELTAMETHRIN; FLUMETHRIN; IMIDACLOPRID; INSECT REPELLENT; PERMETHRIN; PYRETHROID;

ANTIGENIC VARIATION; CANINE LEISHMANIASIS; COST EFFECTIVENESS ANALYSIS; DOG; ENVIRONMENT; HOST; HUMAN; LEISHMANIA INFANTUM; LEISHMANIASIS; NONHUMAN; PARASITE VECTOR; PUBLIC HEALTH; REVIEW; VACCINATION; VECTOR CONTROL; VETERINARY MEDICINE; ZOONOSIS;

ANIMALS; COST-BENEFIT ANALYSIS; DOG DISEASES; DOGS; ENVIRONMENT; HUMANS; INSECT REPELLENTS; INSECT VECTORS; INSECTICIDES; LEISHMANIA INFANTUM; LEISHMANIASIS VACCINES; LEISHMANIASIS, VISCERAL; PSYCHODIDAE; PUBLIC HEALTH; PYRETHRINS; VACCINATION; ZOONOSES;

CANIS FAMILIARIS; LEISHMANIA INFANTUM;

EID: 84879463480     PISSN: 14714922     EISSN: 14715007     Source Type: Journal    
DOI: 10.1016/j.pt.2013.05.003     Document Type: Review

References (76)

1. Dantas-Torres F., et al. Canine leishmaniosis in the Old and New Worlds: unveiled similarities and differences. Trends Parasitol. 2012, 28:531-538.
2. Maroli M., et al. Phlebotomine sand flies and the spreading of leishmaniases and other diseases of public health concern. Med. Vet. Entomol. 2013, 27:123-147.
3. Otranto D., et al. Prevention of endemic canine vector-borne diseases using imidacloprid 10% and permethrin 50% in young dogs: a longitudinal field study. Vet. Parasitol. 2010, 172:323-332.
4. Maroli M., et al. The northward spread of leishmaniasis in Italy: evidence from retrospective and ongoing studies on the canine reservoir and phlebotomine vectors. Trop. Med. Int. Health 2008, 13:256-264.
5. Petersen C.A., Barr S.C. Canine leishmaniasis in North America: emerging or newly recognized?. Vet. Clin. North Am. Small Anim. Pract. 2009, 39:1065-1074.
6. Otranto D., et al. Toward diagnosing Leishmania infantum infection in asymptomatic dogs in an area where leishmaniasis is endemic. Clin. Vaccine Immunol. 2009, 16:337-343.
7. Fernandéz-Guerrero M.L., et al. Visceral leishmaniasis in immunocompromised patients with and without AIDS: a comparison of clinical features and prognosis. Acta Trop. 2004, 90:11-16.
8. Naucke T.J., Lorentz S. First report of venereal and vertical transmission of canine leishmaniosis from naturally infected dogs in Germany. Parasit. Vectors 2012, 5:67.
9. Alvar J., et al. Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 2012, 7:e35671.
10. Moreno J., Alvar J. Canine leishmaniasis: epidemiological risk and the experimental model. Trends Parasitol. 2002, 18:399-405.
11. Otranto D., et al. Prevention of canine leishmaniosis in a hyper-endemic area using a combination of 10% imidacloprid/4.5% flumethrin. PLoS ONE 2013, 8:e56374.
12. Romero G.A., Boelaert M. Control of visceral leishmaniasis in Latin America - a systematic review. PLoS Negl. Trop. Dis. 2010, 4:e584.
13. Alexander B., Maroli M. Control of phlebotomine sandflies. Med. Vet. Entomol. 2003, 17:1-18.
14. Dantas-Torres F., et al. Seroepidemiological survey on canine leishmaniasis among dogs from an urban area of Brazil. Vet. Parasitol. 2006, 310:54-60.
15. Costa C.H., et al. Asymptomatic human carriers of Leishmania chagasi. Am. J. Trop. Med. Hyg. 2002, 66:334-337.
16. Molina R., et al. Infectivity of dogs naturally infected with Leishmania infantum to colonized Phlebotomus perniciosus. Trans. R. Soc. Trop. Med. Hyg. 1994, 88:491-493.
17. Michalsky E.M., et al. Infectivity of seropositive dogs, showing different clinical forms of leishmaniasis, to Lutzomyia longipalpis phlebotomine sand flies. Vet. Parasitol. 2007, 147:67-76.
18. Miró G., et al. Canine leishmaniosis - new concepts and insights on an expanding zoonosis: part two. Trends Parasitol. 2008, 8:371-377.
19. Baneth G. Leishmaniases. Infectious Diseases of the Dog and Cat 2006, 685-698. Saunders/Elsevier. 3rd edn. C.E. Greene (Ed.).
20. Paiva Cavalcanti M., et al. The development of a real-time PCR assay for the quantification of Leishmania infantum DNA in canine blood. Vet. J. 2009, 182:356-358.
21. Maroli M., et al. Guidelines for prevention of leishmaniasis in dogs. J. Am. Vet. Med. Assoc. 2010, 236:1200-1206.
22. Tarallo V.D., et al. Phlebotomine sand fly population dynamics in a leishmaniasis endemic peri-urban area in southern Italy. Acta Trop. 2010, 116:227-234.
23. Costa P.L., et al. Ecology of Lutzomyia longipalpis in an area of visceral leishmaniasis transmission in north-eastern Brazil. Acta Trop. 2013, 26:99-102.
24. Killick-Kendrick R. The biology and control of phlebotomine sand flies. Clin. Dermatol. 1999, 17:279-289.
25. Stanneck D., et al. The synergistic action of imidacloprid and flumethrin and their release kinetics from collars applied for ectoparasite control in dogs and cats. Parasit. Vectors 2012, 5:73.
26. ®) in dogs and cats naturally infested with fleas and/or ticks in multicentre clinical field studies in Europe. Parasit. Vectors 2012, 5:66.
27. Halbig P., et al. Further evidence that deltamethrin-impregnated collars protect domestic dogs from sandfly bites. Med. Vet. Entomol. 2000, 14:223-226.
28. David J.R., et al. Deltamethrin-impregnated dog collars have a potent anti-feeding and insecticidal effect on Lutzomyia longipalpis and Lutzomyia migonei. Mem. Inst. Oswaldo Cruz 2001, 96:839-847.
29. Reithinger R., et al. Topical insecticide treatments to protect dogs from sand fly vectors of leishmaniasis. Emerg. Infect. Dis. 2001, 7:872-876.
30. Mencke N., et al. Repellent efficacy of a combination containing imidacloprid and permethrin against sand flies (Phlebotomus papatasi) on dogs. Parasitol. Res. 2003, 90:108-111.
31. Molina R., et al. Evaluation of a spray of permethrin and pyriproxyfen for the protection of dogs against Phlebotomus perniciosus. Vet. Rec. 2006, 159:206-209.
32. Mirò G., et al. Evaluation of the efficacy of a topically administered combination of imidacloprid and permethrin against Phlebotomus perniciosus in dog. Vet. Parasitol. 2007, 143:375-379.
33. Reithinger R., et al. Are insecticide-impregnated dog collars a feasible alternative to dog culling as a strategy for controlling canine visceral leishmaniasis in Brazil?. Int. J. Parasitol. 2004, 34:55-62.
34. Maroli M., et al. Evidence for an impact on the incidence of canine leishmaniasis by the use of deltamethrin-impregnated dog collars in southern Italy. Med. Vet. Entomol. 2001, 15:358-363.
35. Killick-Kendrick R., et al. Protection of dogs from the bites of phlebotomine sandflies by deltamethrin collars for the control of canine leishmaniasis. Med. Vet. Entomol. 1997, 11:105-111.
36. Gavgani A.S., et al. Domestic dog ownership in Iran is a risk factor for human infection with Leishmania infantum. Am. J. Trop. Med. Hyg. 2002, 67:511-515.
37. Otranto D., et al. Efficacy of a combination of 10% imidacloprid/50% permethrin for the prevention of leishmaniasis in kennelled dogs in an endemic area. Vet. Parasitol. 2007, 144:270-278.
38. Palatnik-de-Sousa C.B. Vaccines for leishmaniasis in the fore coming 25 years. Vaccine 2008, 26:1709-1724.
39. Mayrink W., et al. Phase I and II open clinical trials of a vaccine against Leishmania chagasi infection in dogs. Mem. Inst. Oswaldo Cruz 1996, 91:695-697.
40. Mohebali M., et al. Double-blind randomized efficacy field trial of alum precipitated autoclaved Leishmania major vaccine mixed with BCG against canine visceral leishmaniasis in Meshkin-Shahr district, I.R. Iran. Vaccine 2004, 22:4097-4100.
41. Giunchetti R.C., et al. A killed Leishmania vaccine with sand fly saliva extract and saponin adjuvant displays immunogenicity in dogs. Vaccine 2007, 26:623-638.
42. Borja-Cabrera G.P., et al. Long lasting protection against canine kala-azar using FML-QuilA saponin vaccine in an endemic area of Brazil (São Gonçalo do Amaranto, RN). Vaccine 2002, 20:3277-3284.
43. Nogueira F.S., et al. Leishmune 1 vaccine blocks the transmission of canine visceral leishmaniasis. Absence of Leishmania parasite in blood, skin and lymph nodes of vaccinated exposed dogs. Vaccine 2005, 23:4805-4810.
44. Silva V.O., et al. A phase III trial of efficacy of the FML vaccine against canine kala-azar in an endemic area of Brazil (São Gonçalo do Amaranto, RN). Vaccine 2001, 19:1082-1092.
45. Borja-Cabrera G.P., et al. Immunotherapy with the saponin enriched-Leishmune vaccine versus immunochemotherapy in dogs with natural canine visceral leishmaniasis. Vaccine 2010, 28:597-603.
46. Palatnik-de-Sousa C.B., et al. Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune in Brazilian endemic areas. Vaccine 2009, 27:3505-3512.
47. Lemesre J.L., et al. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomized efficacy field trial. Vaccine 2007, 25:4223-4234.
48. Fernandes A.P., et al. Protective immunity against challenge with Leishmania (Leishmania) chagasi in beagle dogs vaccinated with recombinant A2 protein. Vaccine 2008, 26:5888-5895.
49. Gradoni L., et al. Failure of a multi-subunit recombinant Leishmania vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals. Vaccine 2005, 23:5245-5251.
50. Ramiro M.J., et al. Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK. Vaccine 2003, 21:2474-2484.
51. Rafati S., et al. Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinase type I and II of L. infantum. Vaccine 2005, 23:3716-3725.
52. Rodríguez-Cortés A., et al. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge. Vaccine 2007, 25:7962-7971.
53. Solano-Gallego L., et al. The LeishVet Group. LeishVet guidelines for the practical management of canine leishmaniosis. Parasit. Vectors 2011, 4:86.
54. Gradoni L., et al. Leishmania infantum infection rates in Phlebotomus perniciosus fed on naturally infected dogs under antimonial treatment. Med. Vet. Entomol. 1987, 1:339-342.
55. Miró G., et al. Infectivity to Phlebotomus perniciosus of dogs naturally parasitized with Leishmania infantum after different treatments. Parasit. Vectors 2011, 4:52.
56. Silva S.M., et al. Efficacy of combined therapy with liposome-encapsulated meglumine antimoniate and allopurinol in treatment of canine visceral leishmaniasis. Antimicrob. Agents Chemother. 2012, 56:2858-2867.
57. Costa C.H. How effective is dog culling in controlling zoonotic visceral leishmaniasis? A critical evaluation of the science, politics and ethics behind this public health policy. Rev. Soc. Bras. Med. Trop. 2011, 44:232-242.
58. Lu H.G., et al. Separation of Chinese Leishmania isolates into five genotypes by kinetoplast and chromosomal DNA heterogeneity. Am. J. Trop. Med. Hyg. 1994, 50:763-770.
59. Wang J.Y., et al. An outbreak of the desert sub-type of zoonotic visceral leishmaniasis in Jiashi, Xinjiang Uygur Autonomous Region, People's Republic of China. Parasitol. Int. 2010, 59:331-337.
60. Quinnell R.J., Courtenay O. Transmission, reservoir hosts and control of zoonotic visceral leishmaniasis. Parasitology 2009, 136:1915-1934.
61. Madeira M.F., et al. Post mortem parasitological evaluation of dogs seroreactive for Leishmania from Rio de Janeiro, Brazil. Vet. Parasitol. 2006, 138:366-370.
62. Silva D.A., et al. Laboratory tests performed on Leishmania seroreactive dogs euthanized by the leishmaniasis control program. Vet. Parasitol. 2011, 179:257-261.
63. Nunes C.M., et al. Dog culling and replacement in an area endemic for visceral leishmaniasis in Brazil. Vet. Parasitol. 2008, 153:19-23.
64. Costa C.H.N., et al. Infectivity of symptomatic and asymptomatic, non-HIV and HIV/Leishmania infantum infected, patients to Lutzomyia longipalpis. Abstract Book of the Fifth World Congress on Leishmaniasis 2013, 244-245.
65. Oliveira F., et al. Sand flies, Leishmania, and transcriptome-borne solutions. Parasitol. Int. 2009, 58:1-5.
66. Vlkova M., et al. Canine antibody response to Phlebotomus perniciosus bites negatively correlates with the risk of Leishmania infantum transmission. PLoS Negl. Trop. Dis. 2011, 5:e1344.
67. Gomes R.B., et al. Antibodies against Lutzomyia longipalpis saliva in the fox Cerdocyon thous and the sylvatic cycle of Leishmania chagasi. Trans. R. Soc. Trop. Med. Hyg. 2007, 101:127-133.
68. Hostomska J., et al. Kinetics of canine antibody response to saliva of the sand fly Lutzomyia longipalpis. Vector Borne Zoonotic Dis. 2008, 8:443-450.
69. Gavgani A.S., et al. Effect of insecticide-impregnated dog collars on incidence of zoonotic visceral leishmaniasis in Iranian children: a matched-cluster randomised trial. Lancet 2002, 360:374-379.
70. Dantas-Torres F., Brandão-Filho S.P. Geographical expansion of visceral leishmaniasis in the State of Pernambuco. Rev. Soc. Bras. Med. Trop. 2006, 39:352-356.
71. Giffoni J.H., et al. Evaluation of 65% permethrin spot-on for prevention of canine visceral leishmaniasis: effect on disease prevalence and the vectors (Diptera: Psychodidae) in a hyperendemic area. Vet. Ther. 2002, 3:485-492.
72. Ferroglio E., et al. Evaluation of 65% permethrin spot-on and deltamethrin-impregnated collars for canine Leishmania infantum infection prevention. Zoonoses Public Health 2008, 55:145-148.
73. Foglia Manzillo V., et al. Deltamethrin-impregnated collars for the control of canine leishmaniasis: evaluation of the protective effect and influence on the clinical outcome of Leishmania infection in kennelled stray dogs. Vet. Parasitol. 2006, 142:142-145.
74. Aoun K., et al. [Efficacy of deltamethrine-impregnated collars Scalibor in the prevention of canine leishmaniasis in the area of Tunis]. Arch. Inst. Pasteur Tunis 2008, 85:63-68. (in French).
75. Borja-Cabrera G.P., et al. Immunogenicity assay of the Leishmune vaccine against canine visceral leishmaniasis in Brazil. Vaccine 2008, 26:4991-4997.
76. Palatnik-de-Sousa C.B., et al. FML vaccine against canine visceral leishmaniasis: from second-generation to synthetic vaccine. Exp. Rev. Vaccines 2008, 7:833-851.